SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-102044
Filing Date
2020-09-03
Accepted
2020-09-03 08:37:11
Documents
17
Period of Report
2020-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2029771d5_8k.htm   iXBRL 8-K 33546
2 EXHIBIT 5.1 tm2029771d5_ex5-1.htm EX-5.1 8957
3 EXHIBIT 5.2 tm2029771d5_ex5-2.htm EX-5.2 9249
4 EXHIBIT 10.1 tm2029771d5_ex10-1.htm EX-10.1 23842
8 GRAPHIC tm2029771d5_ex5-1img001.jpg GRAPHIC 2594
9 GRAPHIC tm2029771d5_ex5-2img001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-20-102044.txt   271965

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idra-20200902.xsd EX-101.SCH 3195
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20200902_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20200902_pre.xml EX-101.PRE 22716
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2029771d5_8k_htm.xml XML 3615
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 201158332
SIC: 2836 Biological Products, (No Diagnostic Substances)